BIT/1BDX (BIT/1BDX)

Borsa Italiana: BIT/1BDX · EUR

€158

-0.20 (-0.1%)· Recorded snapshot

Market cap	47.7B
Revenue (ttm)	19.7B
Net income (ttm)	824.5M
EPS (ttm)	€2.99
P/E (trailing)	52.7x
P/E (forward)	14.6x
Dividend	€3.62 (2.30%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 19.7B
Net income (ttm): 824.5M
EPS (ttm): €2.99
P/E (trailing): 52.7x
P/E (forward): 14.6x
Market cap: 47.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E14.6

P25 13.7P50 18.9P75 26.3

Trailing P/E52.7

P25 18.3P50 24.5P75 35.6

ROE6.6

P25 2.4P50 10.6P75 22.2

ROIC7.9

P25 5.1P50 9P75 18.8

Benchmarks · 1M

All BIT/1BDX indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	IT
Earnings date	2026-11-05
Employees	72,000
Employees change	-2,000
Employees growth	-2.7%
Enterprise value	EUR 62.1B
Exchange	Borsa Italiana
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Founded	1897
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	US0758871091
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Market cap	EUR 47.7B
Next earnings date	2026-11-05
Price	EUR 157.55
Price currency	EUR
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-02
Symbol	bit/1BDX
Website	https://www.bd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	65.44x
Average P/E ratio (3Y)	42.8x
Average P/E ratio (5Y)	42.69x
Earnings yield	1.9%
EV/Earnings	75.35x
EV/EBIT	18.87x
EV/EBITDA	10.96x
EV/FCF	27.42x
EV/Sales	3.08x
FCF / EV yield	3.65%
FCF yield	4.75%
Forward P/E	14.62x
Graham number	65.79719
Graham upside	-58.24%
Lynch fair value	EUR 13.62
Lynch upside	-91.35%
P/(FCF - SBC) ratio	23.62x
P/(OCF - SBC) ratio	17.81x
P/B ratio	2.23x
P/E ratio	52.67x
P/FCF ratio	21.04x
P/OCF ratio	16.3x
P/S ratio	2.42x
Price/EBITDA ratio	8.9x
Sector forward P/E	16.76x
Sector P/E	20.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.31%
EBITDA margin	27.22%
Effective tax rate	12.29%
FCF margin	11.22%
Gross margin	46.94%
Operating margin	16.31%
Pretax margin	8.36%
Profit margin	4.19%
Profit per employee	EUR 11,452
Profitable quarters	1
Profitable years	34
Revenue per employee	EUR 273,337
ROA	4.34%
ROA (5Y)	3.22%
ROCE	8.88%
ROE	6.61%
ROE (5Y)	6.51%
ROIC	7.93%
ROIC (5Y)	6.09%
SBC / revenue	1.26%
Tax / revenue	1.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-39.21%
EPS growth (Q)	-31.39%
EPS growth 10Y	-4.43%
EPS growth 3Y	-15.54%
EPS growth 5Y	-12.12%
EPS growth years	0
FCF growth	0.86%
FCF growth (Q)	-44.41%
FCF growth 3Y	14.1%
FCF growth 5Y	-9.32%
Gross profit growth	21.08%
Gross profit growth (Q)	3.58%
Gross profit growth 3Y	7.11%
Gross profit growth 5Y	3.11%
Net income growth	-40.57%
Net income growth (Q)	-34.32%
Net income growth 3Y	-15.87%
Net income growth 5Y	-12.76%
Net income growth years	0
OCF growth	2.96%
OCF growth (Q)	-40.13%
OCF growth 10Y	2.81%
OCF growth 3Y	8.2%
OCF growth 5Y	-8.38%
Operating income growth	29.98%
Operating income growth (Q)	-3.21%
Operating income growth 3Y	13.6%
Operating income growth 5Y	2.7%
Revenue growth	18.49%
Revenue growth (Q)	5.44%
Revenue growth (QoQ)	5.71%
Revenue growth 10Y	6.21%
Revenue growth 3Y	5.69%
Revenue growth 5Y	3.35%
Revenue growth quarters	4
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -659.1M
Depreciation and amortization	EUR 2.2B
EBIT	EUR 3.2B
EBITDA	EUR 5.4B
EPS	EUR 2.99
Financing cash flow	EUR -1.8B
Free cash flow	EUR 2.3B
Free cash flow minus SBC	EUR 2B
Gross profit	EUR 9.2B
Income taxes	EUR 202.2M
Investing cash flow	EUR -959.3M
Net borrowing	EUR -2B
Net cash flow	EUR 127.8M
Net income	EUR 824.5M
Operating cash flow minus SBC	EUR 2.7B
Operating income	EUR 3.2B
Revenue	EUR 19.7B
Stock-based compensation	EUR 247.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.29
Book value per share	EUR 78.46
Debt / EBITDA	2.66
Debt / equity	0.69
Debt / FCF	6.49
Goodwill	EUR 23.3B
Interest coverage	6.23
Long-term assets	EUR 37.1B
Long-term liabilities	EUR 14.6B
Net cash (debt)	EUR -14.1B
Net cash / market cap	-29.56%
Net debt / EBITDA	2.63
Net debt / equity	0.66
Net debt / FCF	6.22
Piotroski F-Score	7
Property, plant and equipment	EUR 5.5B
Shareholders' equity	EUR 21.4B
Tangible book value	EUR -8.4B
Tangible book value per share	EUR -30.69
Total assets	EUR 44.4B
Total cash	EUR 620.6M
Total debt	EUR 14.7B
Total liabilities	EUR 23B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.43
Current assets	EUR 7.3B
Current liabilities	EUR 8.4B
Current ratio	0.87
Inventory turnover	3.28
Net working capital	EUR 1.2B
Quick ratio	0.33
Working capital	EUR -1.1B
Working capital turnover	-91.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.14%
Dividend growth	27.5%
Dividend growth (3Y)	1.82%
Dividend growth (5Y)	5.51%
Dividend growth years	0
Dividend payment date	2026-09-30
Dividend payment years	9
Dividend payout frequency	Quarterly
Dividend per share	EUR 3.62
Dividend yield	2.3%
Ex-dividend date	2026-09-08
Last dividend	EUR 0.90
Payout ratio	124.42%
Shareholder yield	4.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 140.50
1D price change	-0.13%
1M price change	-2.96%
1M total return	-2.4%
1W price change	-1.41%
1W total return	-1.41%
1Y price change	-3.05%
1Y return CAGR	28.6%
1Y total return	28.58%
20-day SMA	EUR 157.89
200-day SMA	EUR 146.62
3M price change	19.36%
3M total return	20.04%
3Y price change	-35.96%
3Y return CAGR	-4.31%
3Y total return	-12.39%
50-day SMA	EUR 156.75
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 180.90
52-week high date	2026-01-19
52-week low	EUR 122.30
52-week low date	2026-05-25
5Y price change	-24.98%
5Y return CAGR	1.6%
5Y total return	8.25%
6M price change	16.88%
6M total return	18.36%
All-time high	EUR 263.50
All-time high date	2022-08-22
All-time low	EUR 122.30
All-time low date	2026-05-25
Average true range (ATR)	EUR 1.76
Average volume	1.4
Change from 52-week high	-12.91%
Change from 52-week low	28.82%
Change from all-time high	-40.21%
Change from all-time low	28.82%
Change from open	0%
Day's gap	-0.13%
High price	EUR 157.55
Low price	EUR 157.55
Monthly RSI	45.09
Open price	EUR 157.55
Previous close	EUR 157.75
Price vs 150-day SMA	12.13%
Price vs 20-day SMA	-0.22%
Price vs 200-day SMA	7.46%
Price vs 50-day SMA	0.51%
Relative volume	0.32
RSI	48.79
Sharpe ratio	0.72
Sharpe ratio (3Y)	-0.13
Sharpe ratio (5Y)	0.05
Sortino ratio	1.24
Sortino ratio (3Y)	0.01
Sortino ratio (5Y)	0.28
Weekly RSI	54.85
YTD price change	-5%
YTD total return	25.3%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	271.7M
Shares change (QoQ)	-1.95%
Shares change (YoY)	-2.14%
Shares held by insiders	0.17%
Shares held by institutions	98.3%
Short ratio	5.1 days

Deeper analysis on BIT/1BDX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BIT/1BDX report

Is a complete BIT/1BDX research report available?

No complete published report is available for bit/1BDX (BIT/1BDX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BIT/1BDX (BIT/1BDX)

Price

Financial snapshot

Fair-value bridge

Latest news · BIT/1BDX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BIT/1BDX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BIT/1BDX

Frequently asked questions